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Human leptospirosis in The Federated States of
Micronesia: a hospital-based febrile illness survey
Susannah Colt1, Boris I Pavlin2*, Jacob L Kool3, Eliaser Johnson4, Judith P McCool5 and Alistair J Woodward5
Abstract
Background: Human leptospirosis is an emerging infectious disease of global significance, and is endemic to
several countries in the Pacific. Zoonotic transmission dynamics combined with diagnostic challenges lead to
difficulties in prevention and identification of cases. The Federated States of Micronesia (FSM) lacks surveillance
data for human leptospirosis. This hospital-based serologic survey sought to estimate the burden of leptospirosis,
collect information relating to associated factors, and assess the leptospirosis point-of-care rapid diagnostic test
(RDT) commonly used in FSM.
Methods: A four-month hospital-based survey was conducted in Pohnpei State, FSM in 2011. Patients with
undifferentiated fevers presenting to hospital were referred for enrolment by physicians. Consenting participants
provided paired blood specimens 10–30 days apart, and responded to interview questions regarding demographics,
clinical symptoms, exposure to animals, and environmental exposure. Blood samples were subjected to
immunochromatographic RDT and confirmed by microscopic agglutination test (MAT).
Results: Of 54 participants tested by MAT, 20.4% (95% confidence interval [CI] 10.1–30.6%) showed serologic
evidence of acute infection. Occupation student (odds ratio [OR], 17.5; 95% CI: 1.9–161.1) and recreational
gardening (OR, 8.6; 95% CI: 1.0-73.8), identified by univariate logistic regression, were associated with infection.
The local rapid diagnostic test (RDT) performed with a sensitivity of 69.2 (42.3-89.3 CI) and specificity of 90.0
(81.6-95.6 CI) compared to MAT.
Conclusions: This study demonstrated a high burden of leptospirosis in Pohnpei. Further work is warranted to
identify additional risk factors and opportunities to control leptospirosis in Pohnpei and other Pacific settings.
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Background
Human leptospirosis is a widespread zoonotic disease
caused by bacteria of the genus Leptospira [1]. Leptos-
pira are spirochetes with over 200 pathogenic serovars
identified worldwide [2]. The global burden of this dis-
ease is unknown due to underreporting, misdiagnosis,
and lack of confirmatory diagnostic resources [3]. While
cases can remain asymptomatic, infection often induces
an acute febrile illness with a broad spectrum of symp-
toms of variable morbidity ranging from mild to fatal.
Presentation is described in four clinical categories
including a mild influenza-like illness; jaundice, renal
failure, haemorrhages and cardiac arrhythmias, termed
Weil syndrome; meningitis or meningoencephalitis; and
pulmonary haemorrhage with respiratory failure [4]. Un-
treated, Leptospirosis can result in chronic morbidities
and in some cases death. Rough estimates measure case
fatality between <5 to 30% worldwide [2]. Human trans-
mission occurs from direct contact with carrier animals or
via indirect contact with pathogenic leptospires present in
the environment [5]. Leptospira carrier animals, including
cattle, pigs, dogs, and rodents, excrete high concentrations
of the bacteria in urine, contaminating fresh water and soil
[6]. Areas most affected are humid tropical or subtropical
climates where populations live in close proximity with
feral or domestic animals carrying the disease [7]. Lepto-
spirosis is considered an emerging infectious disease of
significant concern in tropical developing regions includ-
ing Pacific Island populations [8].
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While published data finds endemic conditions in
many Pacific Island countries, it is likely that the true
extent is underestimated [9]. Rates in hyperendemic
Pacific Island countries including French Polynesia and
New Caledonia are much greater than those reported in
the Federated States of Micronesia (FSM) [10]. A survey
conducted from 2003–2005 found 69 confirmed cases
from 263 suspected cases from seven Western Pacific
Islands and recommended further investigation, specific-
ally in FSM [11]. Human leptospirosis in FSM was first
described in Kosrae State in 1990 (D. Upson, unpub-
lished observations) and then in Pohnpei State in 1991
[12] and 1993 [13], but there has been limited surveil-
lance to date. An animal study conducted from 1995–
1996 isolated Leptospira from dogs, pigs, and rodents
throughout FSM, including Pohnpei State [14]. In 2010,
an outbreak investigation in Chuuk State, FSM revealed
2 confirmed cases of leptospirosis (involving different
serovars, suggesting more than one independent intro-
duction from animal reservoirs) from a sample of 10 fe-
brile patients [15]. A significant barrier to surveillance is
FSM’s lack of laboratory facilities able to produce con-
firmatory diagnoses. In Pohnpei, the standard of care for
hospital patients suspected of leptospirosis is precaution-
ary treatment with antibiotics, although some patients
may be given an acute phase rapid leptospirosis titre test
if available. For confirmatory analysis, suspected case
samples must be shipped overseas.
Risk factors for transmission present in FSM include: a
humid tropical climate; close association between ani-
mals and humans; horticultural or pastoral livelihoods;
slaughter or food preparation of carrier animals; and rec-
reational activities like swimming, hiking, and children’s
outdoor play. Pohnpei, FSM experiences high annual
rainfall contributing to a potentially endemic environ-
ment. Compounding these factors, climate change esti-
mates predict that these conditions will worsen with
increasing temperatures and annual rainfall [16].
This study sought to investigate the presence of
human leptospirosis in Pohnpei State. Our primary
objective was to quantify cases of leptospirosis amongst
patients presenting to the health services with undiffer-
entiated fevers and collect information relating to risk
factors associated with contracting leptospirosis. A sec-
ondary objective of the study was to determine the sen-
sitivity and specificity of the leptospirosis point-of-care
rapid diagnostic test used in Pohnpei, when compared
with the reference standard microscopic agglutination
test (MAT) results.
Methods
A hospital-based serosurvey was conducted in Pohnpei
State, FSM from June-September 2011. Pohnpei State,
with a population of roughly 35,000, is served by two
main hospitals and several small dispensary clinics. Eli-
gible participants included individuals older than 10 years
who presented to either of the hospitals on the island
(Pohnpei State Hospital and the private Genesis Hos-
pital) with reported fever or measured temperature ≥ 38
C/100.4 F, and two or more of the following symptoms:
headache, fatigue, myalgia, chills, conjunctival suffusion,
anuria or oliguria, cough, jaundice, haemorrhages, vomit-
ing, diarrhoea, meningeal irritation, cardiac arrhythmias,
or skin rash. Exclusion criteria included diagnosed upper
respiratory illness, pneumonia, or influenza. Confirmed
diagnosis of dengue would have been considered exclu-
sionary, but dengue is not routinely tested in Pohnpei. Pa-
tients were referred to the study by hospital physicians.
Written consent was provided by the patient or family
member.
Enrolled participants provided paired blood specimens
and responded to interview questions. A primary blood
specimen was collected at enrolment, and a secondary
blood specimen was collected during a follow-up study
visit, between 10–30 days following the date of symp-
toms onset. Collected blood specimens were subject to a
rapid leptospirosis titre test (SD BIOLINE Leptospira
IgG/IgM test device, Korea) performed at the Pohnpei
State Hospital laboratory. Portions of all collected blood
serum specimens were saved and frozen for confirmatory
MAT, conducted at the WHO/FAO/OIE Collaborating
Centre for Reference and Research on Leptospirosis in
Queensland, Australia. A positive MAT result was defined
as a titre of 1:400 or greater on a single specimen or a
four-fold increase between acute and convalescent speci-
mens [8].
Information including demographics, clinical symp-
toms, exposure to animals, and environmental exposure
was collected during a face-to-face participant interview.
If participants did not speak English, a translator assisted
with the interview. Participants were compensated for
time and cooperation.
Statistical analysis was carried out using IBM® SPSS®
Statistics 20. Odds ratios (OR) and 95% confidence inter-
vals (CIs) were calculated to measure the association be-
tween participant-reported symptoms, demographics,
and environmental exposures and leptospirosis cases
confirmed by MAT. Logistic regression was used to
compare risk factor categories to MAT outcome. Statis-
tical significance was determined using Fisher’s exact test
for binomial analyses and Wald’s test for multinomial
analyses. Ethical approval was granted by The University
of Auckland Ethics Committee and by the Pohnpei State
Department of Health.
Results
During the study period, 66 participants were enrolled
out of 69 eligible hospital patients. One patient declined
Colt et al. BMC Infectious Diseases 2014, 14:186 Page 2 of 6
http://www.biomedcentral.com/1471-2334/14/186
to participate. Two suspected cases died prior to enrol-
ment. On average, patients presented to hospital 3 days
(2.12-3.85 CI) following the onset of symptoms. Of
those enrolled, 54 were tested for leptospirosis by MAT
(Table 1). Some enrolled patients were not tested by
MAT if they left the hospital prior to serum collection
and could not be contacted by the researcher. Based on
MAT results, 20.4% (10.1-30.6% CI) of screened partici-
pants were confirmed cases of leptospirosis. The 11 con-
firmed cases were associated with serovars Copenhageni,
Ballum, and LT751-Pohnpei based on a 20 serovar MAT
panel (Table 2). A total of 12 distinct serovars were re-
active (titre >1:50) in 13 participant serum samples, yet
some of these titres measured below diagnostic thresh-
olds. While the MAT serovar panel indicates reactivity,
isolation of serovar-specific leptospires is required for
definitive typing [17]. Compared to the reference stand-
ard MAT, the RDT performed with a sensitivity of 69.2
(42.3-89.3 CI) and specificity of 90.0 (81.6-95.6 CI) on sin-
gle serum specimens (Table 3). The RDT positive predict-
ive value (PPV) for this sample was 56.3 (32.4-78.2 CI)
and the negative predictive value was 94.0 (86.7-98.1 CI).
Amongst those who were screened, occupation was as-
sociated with leptospirosis (Table 4). Those in the stu-
dent occupation group, all under the age of 24 years and
enrolled in education levels ranging from primary to
tertiary, OR = 17.5 (1.9-161.1 CI, P = 0.012), were more
frequently associated with leptospirosis compared to
farming and other occupations. Participants who regu-
larly tended gardens or crops were also more likely
to test positive for leptospirosis, OR = 8.6 (1.0-73.8 CI,
P = 0.035). Other, less certain associations include the
link between leptospirosis and age 10–24 years, OR = 4.0
(1.0-16.2 CI); the presence of a wound on the leg or foot
at the time of enrolment, OR = 4.4 (1.1-17.8 CI); swim-
ming or standing in fresh water, OR = 3.8 (0.9-15.2 CI);
and using fresh water streams as a source for drinking
or bathing, OR = 1.7 (0.4-6.4 CI) and OR = 1.2 (0.3-4.7
CI) respectively. Most clinical symptoms reported by
participants at the time of enrolment were not found to be
strong indicators for leptospirosis (Table 5). Vomiting
was more common amongst cases, OR = 4.8 (1.1-20.9 CI,
P = 0.041).
Discussion
This study represents the first serosurvey to identify
cases of human leptospirosis in The Federated States of
Micronesia, and it confirms that the burden of disease
due to leptospirosis is high. It was suspected that Leptos-
pira infection occurred in Pohnpei State, but very few
confirmed cases had been documented by the State De-
partment of Health Services. The gold standard MAT is
available in only a few reference laboratories worldwide,
rendering cost and clinical timeliness prohibitive. During
the four month recruitment period, 11 hospital patients
seeking treatment for febrile illness in Pohnpei State tested
positive for leptospirosis by MAT. For the purposes of this
Table 1 Recruitment and enrolment
Participants Total
Patients recruited 67
Participants enrolled 66
Participants receiving rapid diagnostic test 62
Both acute and convalescent 42
Acute only 18
Convalescent only 2
Participants receiving MAT 54
Both acute and convalescent 29
Acute only 13
Convalescent only 12
Table 2 Serovars detected from MAT
Serovar Participants with titre >50 Confirmed Cases
Pomona 1
Sejroe
Tarassovi
Grippotyphosa
Celledoni 5
Copenhageni 10 5
Australis 4
Pyrogenes
Canicola 3
Hebdomadis 2
Mini
Sarmin
Autumnalis 2
Cynopteri 4
Ballum 2 1
Bataviae
Djasiman 2
Javanica
Panama 1
Shermani
LT751 (Pohnpei*) 12 5
*Isolated from rodents and pigs during a Pohnpei survey in February 1996.
Pohnpei is the proposed name for the LT751 serovar.
Table 3 Accuracy of leptospirosis rapid diagnostic
test (RDT)
MAT titre >400 Agreement % (95% CI)
Positive 13 9 69.2 42.3–89.3
Negative 70 63 90.0 81.6–95.6
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study, subjects with single specimen titres of 1:400 or
higher were considered MAT positive, but in highly en-
demic settings, a single MAT specimen may not be as
specific as a four-fold increase between paired sera speci-
mens. This is a small study, and further investigation is
needed to confirm the magnitude of the problem. How-
ever, our findings suggest that leptospirosis may be widely
distributed throughout Pohnpei State. Of note also, the
study suggests that serovar LT751 is present in humans in
FSM. This serovar was first identified in rats and pigs in
Pohnpei in 1995 [14], was tentatively named “Pohnpei,”
and is currently undergoing confirmation by the Inter-
national Committee on Systematic Bacteriology [18].
Amongst people attending hospital with fever, occupa-
tion was linked to Leptospira infection, as was the regu-
lar tending of gardens or crops. While farming as an
occupation was not more common amongst the lepto-
spirosis cases, tending gardens or crops is an activity re-
ported by participants across all occupation categories.
Tending crops of banana, taro, and yam are common for
Pohnpeian males while females maintain the land and
gardens surrounding the home. Although rainfall in
Pohnpei is high with an annual accumulation of 187
inches (475 cm) per year, seasonal distribution of lepto-
spirosis cases was not considered in this study due to
the low seasonal variability of rainfall in Pohnpei [19].
Interestingly, the presence of pigs, dogs, or rats was not
associated with leptospirosis cases, presumably because
these animals are found near most Pohnpeian homes.
While pig slaughter is customary at cultural feasts, this
factor was not linked to cases as few participants re-
ported involvement with recent slaughter. The positive
association between being a student and acquiring lepto-
spirosis is intriguing. While specific risk factors amongst
students were not further explored, it is possible that
certain behaviours characteristic of school-aged persons
in Pohnpei (e.g., playing in mud, caring for domestic
pigs, and routine travel by foot) may put such persons at
increased risk. This could be explored in future studies.
Affordable and effective diagnostics are necessary in
developing settings, where leptospirosis burden is high-
est. Evaluation for the specific RDT locally available to
Pohnpei State hospitals had not been performed in FSM
and is not widely referenced in the literature. In this
Table 4 Univariate analysis of demographics and environmental exposures
Factors by category Case frequency% (n) Odds ratio (95% CI) P value
Sex
Male 27.3 (33) 3.6 (0.7–18.5) 0.170
Age
10–24 35.0 (20) 4.0 (1.0–16.2) 0.077
Occupation
Other 3.8 (26) Reference
Farming 27.3 (11) 9.4 (0.9–103.3) 0.067
Student 41.2 (17) 17.5 (1.9–161.1) 0.012
Education Level
Below secondary 20.7 (29) 1.0 (0.3–3.9) 1.000
Water source*†
Drinking from stream 26.3 (19) 1.7 (0.4–6.4) 0.496
Bathing from stream 22.7 (22) 1.2 (0.3–4.7) 1.000
Animals around home*†
Pigs 16.3 (43) 0.3 (0.1–1.3) 0.187
Dogs 19.4 (36) 0.8 (0.2–3.2) 0.730
Rats 20.0 (40) 0.8 (0.2–3.8) 1.000
Environment/behaviour*
Walk through mud‡ 26.2 (42) Undefined 0.096
Wound on legs or feet† 40.0 (15) 4.4 (1.1–17.8) 0.056
Swim or stand in fresh water‡ 35.0 (20) 3.8 (0.9–15.2) 0.081
Tend gardens or crops‡ 31.2 (32) 8.6 (1.0–73.8) 0.035
Recent pig slaughter† 16.7 (6) 0.7 (0.8–7.1) 1.000
*Each exposure is not mutually exclusive.
†Based on 53 responses.
‡Based on 52 responses.
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study, the RDT performed well against the MAT but not
as accurately as the package insert indicates [sensitivity
of 96.3 (53/55) and specificity of 95.3 (143/150)] (SD
BIOLINE Leptospira IgG/IgM Test Package Insert, un-
published observations). As indicated by the PPV, only
56.3% of serum specimens positive by RDT were found
positive by MAT. In addition to RDT performance, the
timing of the RDT compared to patient seroconversion
must be considered. Given that patients presented to
hospital an average of 3 days following symptoms, and
the RDT is unreliable before 7 days of symptoms, the
RDT should not be utilized as a clinical diagnostic tool
in the acute phase. Therefore, clinicians should continue
to treat patients based on clinical symptoms in the ab-
sence of MAT, reserving the RDT for public health
surveillance. As RDT performance is dependent on
serovar-specific antibodies within a given geographic set-
ting [20], further evaluation of rapid tests commonly
used in the Pacific context is recommended.
The major limiting factor in this study is the number
of participants. The study period of four months was
sufficient to confirm leptospirosis cases amongst patients
presenting to hospital with undifferentiated febrile ill-
ness, but the study sample is too small to permit a
comprehensive assessment of risk factors, to establish
any seasonal pattern, or to fully evaluate the local RDT
against the reference standard.
Conclusions
Further efforts to conduct active leptospirosis surveil-
lance throughout FSM are recommended. As rapid test
sensitivity for acute phase samples is not reliable [21],
and MAT is not locally available, routine convalescent
RDTs of suspected cases will strengthen surveillance.
Control efforts must focus on limiting interaction with
carrier animals and preventing animal urine contamin-
ation of fresh water streams. Strengthening community
awareness and education regarding the transmission and
risks of leptospirosis is paramount. Additional research
is warranted to investigate more closely the frequency of
human leptospirosis throughout the other FSM states.
Table 5 Univariate analysis of clinical signs and symptoms
Symptom Case frequency% (n) Odds ratio (95% CI) P value
Headache 22.9 (48) Undefined 0.571
Fatigue 23.9 (46) Undefined 0.322
Neck pain 27.8 (36) 6.2 (0.7–52.7) 0.082
Myalgia 27.0 (37) 5.6 (0.6–47.7) 0.141
Vomiting 34.8 (23) 4.8 (1.1–20.9) 0.041
Conjunctival suffusion 30.0 (30) 4.5 (0.9–23.4) 0.089
Haemorrhage 50.0 (4) 4.4 (0.6–35.9) 0.187
Light sensitivity 35.3 (17) 3.4 (0.9–13.3) 0.143
Joint pain 27.6 (29) 2.7 (0.6–11.5) 0.308
Anorexia 25.0 (36) 2.5 (0.5–13.1) 0.469
Cardiac arrhythmias 30.0 (20) 2.4 (0.6–9.3) 0.296
Difficulty bending neck 28.0 (25) 2.3 (0.6–9.2) 0.313
Diarrhoea 25.0 (28) 1.8 (0.4–6.9) 0.509
Orbital pain 25.0 (24) 1.6 (0.4–6.1) 0.518
Nausea 22.5 (40) 1.5 (0.3–8.6) 0.711
Melanuria 24.0 (25) 1.5 (0.4–5.5) 0.737
Runny Nose 23.8 (21) 1.4 (0.4–5.2) 0.736
Cough 21.9 (32) 1.2 (0.3–4.7) 1.000
Rash 22.2 (9) 1.1 (0.2–6.3) 1.000
Oliguria 20.7 (29) 1.0 (0.3–3.8) 1.000
Shortness of breath 18.8 (16) 0.8 (0.2–3.7) 1.000
Jaundice 14.3 (7) 0.6 (0.1–5.6) 1.000
Abdominal pain 15.8 (38) 0.4 (0.1–1.5) 0.258
Chills 18.8 (48) 0.3 (0.1–2.4) 0.275
Confusion 7.1 (14) 0.2 (0.0–1.9) 0.251
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